| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.837 | 0.004 | 0.837 | Anticonvulsant | 0.227 0.066 DBMET00434 | ||
| 0.632 | 0.002 | 0.632 | Mineralocorticoid receptor antagonist | 0.14 0.005 DBMET00434 | ||
| 0.554 | 0.037 | 0.554 | Cyclophilin D inhibitor | |||
| 0.321 | 0.005 | 0.321 | Glutamate (mGluR) agonist | 0.131 0.016 DBMET00434 | ||
| 0.322 | 0.048 | 0.322 | Cardiotonic | |||
| 0.305 | 0.031 | 0.395 | RNA-directed DNA polymerase inhibitor | 0.395 0.019 DBMET00434 | DBMET00434 | |
| 0.354 | 0.084 | 0.354 | GABA C receptor rho-3 antagonist | 0.334 0.095 DBMET00434 | ||
| 0.24 | 0.005 | 0.24 | Peroxisome proliferator-activated receptor gamma agonist | 0.225 0.005 DBMET00434 | ||
| 0.322 | 0.142 | 0.427 | 5 Hydroxytryptamine release inhibitor | 0.427 0.063 DBMET00434 | DBMET00434 | |
| 0.2 | 0.022 | 0.2 | Ferrochelatase inhibitor | 0.178 0.028 DBMET00434 | ||
| 0.185 | 0.01 | 0.211 | HIV-1 reverse transcriptase inhibitor | 0.211 0.009 DBMET00434 | DBMET00434 | |
| 0.25 | 0.081 | 0.25 | 5 Hydroxytryptamine uptake stimulant | 0.237 0.094 DBMET00434 | ||
| 0.22 | 0.059 | 0.242 | Neurotrophic factor enhancer | 0.242 0.043 DBMET00434 | DBMET00434 | |
| 0.238 | 0.08 | 0.257 | Tyrosine 3 hydroxylase inhibitor | 0.257 0.062 DBMET00434 | DBMET00434 | |
| 0.226 | 0.07 | 0.226 | Peptidyltransferase inhibitor | 0.204 0.094 DBMET00434 | ||
| 0.157 | 0.006 | 0.157 | Progesterone antagonist | 0.063 0.014 DBMET00434 | ||
| 0.19 | 0.04 | 0.204 | Catenin beta inhibitor | 0.204 0.029 DBMET00434 | DBMET00434 | |
| 0.152 | 0.005 | 0.152 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.071 0.018 DBMET00434 | ||
| 0.2 | 0.056 | 0.2 | Lipocortins synthesis antagonist | 0.184 0.067 DBMET00434 | ||
| 0.195 | 0.071 | 0.195 | 5 Hydroxytryptamine 3E antagonist | 0.185 0.093 DBMET00434 | ||
| 0.308 | 0.185 | 0.403 | Caspase 9 stimulant | 0.403 0.109 DBMET00434 | DBMET00434 | |
| 0.253 | 0.131 | 0.253 | Vasodilator, coronary | 0.209 0.174 DBMET00434 | ||
| 0.154 | 0.034 | 0.159 | Ca2+-transporting ATPase inhibitor | 0.159 0.025 DBMET00434 | DBMET00434 | |
| 0.214 | 0.102 | 0.251 | DNA synthesis inhibitor | 0.251 0.066 DBMET00434 | DBMET00434 | |
| 0.144 | 0.034 | 0.144 | Bronchodilator | 0.116 0.047 DBMET00434 | ||
| 0.129 | 0.025 | 0.129 | Cathepsin G inhibitor | 0.066 0.059 DBMET00434 | ||
| 0.265 | 0.17 | 0.265 | Analgesic | |||
| 0.18 | 0.087 | 0.181 | Anesthetic general | 0.181 0.086 DBMET00434 | DBMET00434 | |
| 0.164 | 0.072 | 0.205 | Arachidonic acid antagonist | 0.205 0.029 DBMET00434 | DBMET00434 | |
| 0.116 | 0.028 | 0.116 | Glutamate receptor agonist | |||
| 0.094 | 0.009 | 0.094 | Aldosterone antagonist | 0.058 0.021 DBMET00434 | ||
| 0.244 | 0.16 | 0.294 | Histamine release inhibitor | 0.294 0.127 DBMET00434 | DBMET00434 | |
| 0.153 | 0.069 | 0.157 | GABA C receptor rho-2 antagonist | 0.157 0.065 DBMET00434 | DBMET00434 | |
| 0.148 | 0.067 | 0.182 | Adenylate cyclase stimulant | 0.182 0.024 DBMET00434 | DBMET00434 | |
| 0.211 | 0.132 | 0.211 | Gastrin inhibitor | |||
| 0.118 | 0.04 | 0.118 | Prolactin inhibitor | 0.091 0.066 DBMET00434 | ||
| 0.138 | 0.062 | 0.272 | Alpha-N-acetylglucosaminidase inhibitor | 0.272 0.019 DBMET00434 | DBMET00434 | |
| 0.197 | 0.122 | 0.197 | Spasmolytic | |||
| 0.114 | 0.04 | 0.114 | Antineoplastic alkaloid | 0.112 0.041 DBMET00434 | ||
| 0.22 | 0.148 | 0.298 | Cholesterol antagonist | 0.298 0.093 DBMET00434 | DBMET00434 | |
| 0.149 | 0.078 | 0.149 | Diuretic | |||
| 0.093 | 0.024 | 0.093 | Acetylcholine M5 receptor agonist | |||
| 0.087 | 0.02 | 0.087 | Glutamate (mGluR7) antagonist | 0.069 0.044 DBMET00434 | ||
| 0.075 | 0.009 | 0.075 | Glutamate (mGluR group II) agonist | |||
| 0.071 | 0.009 | 0.071 | Glutamate (mGluR2) agonist | |||
| 0.067 | 0.005 | 0.067 | Calcitonin gene-related peptide antagonist | |||
| 0.078 | 0.02 | 0.078 | Protein 50S ribosomal subunit inhibitor | 0.072 0.023 DBMET00434 | ||
| 0.113 | 0.057 | 0.122 | Electron transport complex I inhibitor | 0.122 0.045 DBMET00434 | DBMET00434 | |
| 0.105 | 0.056 | 0.133 | Anabolic | 0.133 0.028 DBMET00434 | DBMET00434 | |
| 0.063 | 0.016 | 0.081 | Adenylate cyclase 1 inhibitor | 0.081 0.008 DBMET00434 | DBMET00434 | |
| 0.165 | 0.123 | 0.165 | Hypolipemic | 0.144 0.143 DBMET00434 | ||
| 0.063 | 0.021 | 0.063 | Glutamate (mGluR group I) agonist | 0.044 0.037 DBMET00434 | ||
| 0.059 | 0.018 | 0.059 | Glutamate (mGluR5) agonist | |||
| 0.068 | 0.032 | 0.085 | Androgen agonist | 0.085 0.021 DBMET00434 | DBMET00434 | |
| 0.071 | 0.035 | 0.071 | MDM2 inhibitor | |||
| 0.088 | 0.053 | 0.088 | Acetylcholine M3 receptor agonist | |||
| 0.051 | 0.018 | 0.051 | Baculoviral IAP repeat-containing protein inhibitor | 0.047 0.029 DBMET00434 | ||
| 0.043 | 0.012 | 0.043 | Prostaglandin EP3 antagonist | |||
| 0.065 | 0.038 | 0.109 | Carbamoyl phosphate synthetase inhibitor | 0.109 0.018 DBMET00434 | DBMET00434 | |
| 0.028 | 0.004 | 0.028 | Baculoviral IAP repeat-containing protein 3 inhibitor | 0.026 0.005 DBMET00434 | ||
| 0.031 | 0.008 | 0.031 | Acid ceramidase inhibitor | |||
| 0.079 | 0.058 | 0.102 | Glycine receptor antagonist | 0.102 0.031 DBMET00434 | DBMET00434 | |
| 0.083 | 0.062 | 0.09 | Androgen antagonist | 0.09 0.055 DBMET00434 | DBMET00434 | |
| 0.057 | 0.038 | 0.069 | Pregnane X receptor antagonist | 0.069 0.015 DBMET00434 | DBMET00434 | |
| 0.066 | 0.049 | 0.106 | Glutamate (mGluR6) antagonist | 0.106 0.009 DBMET00434 | DBMET00434 | |
| 0.053 | 0.037 | 0.053 | Elastase inhibitor | |||
| 0.053 | 0.038 | 0.063 | Alpha-mannosidase inhibitor | 0.063 0.023 DBMET00434 | DBMET00434 | |
| 0.048 | 0.033 | 0.048 | Carnitine palmitoyltransferase 1B inhibitor | |||
| 0.038 | 0.024 | 0.038 | Renin inhibitor | |||
| 0.114 | 0.103 | 0.144 | Vanilloid 1 agonist | 0.144 0.045 DBMET00434 | DBMET00434 | |
| 0.048 | 0.036 | 0.048 | Cytokine production stimulant | 0.048 0.035 DBMET00434 | ||
| 0.027 | 0.017 | 0.027 | Toll-Like receptor 4 agonist | |||
| 0.013 | 0.004 | 0.013 | Baculoviral IAP repeat-containing protein 2 inhibitor | 0.011 0.004 DBMET00434 | ||
| 0.124 | 0.115 | 0.157 | Growth hormone agonist | 0.157 0.082 DBMET00434 | DBMET00434 | |
| 0.081 | 0.073 | 0.121 | Triose-phosphate isomerase inhibitor | 0.121 0.032 DBMET00434 | DBMET00434 | |
| 0.079 | 0.072 | 0.082 | Estrogen-related receptor beta agonist | 0.082 0.06 DBMET00434 | DBMET00434 | |
| 0.266 | 0.261 | 0.266 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | |||
| 0.046 | 0.041 | 0.046 | HCV NS3/NS4A protease inhibitor | |||
| 0.053 | 0.049 | 0.053 | Calcium channel T-type blocker | |||
| 0.192 | 0.188 | 0.245 | Antithrombotic | 0.245 0.13 DBMET00434 | DBMET00434 | |
| 0.048 | 0.045 | 0.048 | Acetylcholine muscarinic agonist | |||
| 0.098 | 0.095 | 0.118 | Microtubule formation inhibitor | 0.118 0.063 DBMET00434 | DBMET00434 | |
| 0.123 | 0.121 | 0.123 | Pregnane X receptor agonist | |||
| 0.058 | 0.057 | 0.058 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.133 | 0.132 | 0.133 | Psychostimulant | |||
| 0.165 | 0.165 | 0.216 | Nitric-oxide synthase stimulant | 0.216 0.065 DBMET00434 | DBMET00434 | |
| 0.063 | 0.067 | 0.089 | Na+ K+ transporting ATPase inhibitor | 0.089 0.042 DBMET00434 | DBMET00434 | |
| 0.09 | 0.096 | 0.161 | GABA C receptor antagonist | 0.161 0.025 DBMET00434 | DBMET00434 | |
| 0.055 | 0.062 | 0.118 | Phosphofructokinase-1 inhibitor | 0.118 0.026 DBMET00434 | DBMET00434 | |
| 0.083 | 0.092 | 0.102 | GABA C receptor rho-1 antagonist | 0.102 0.059 DBMET00434 | DBMET00434 | |
| 0.082 | 0.091 | 0.092 | Electrolyte absorption antagonist | 0.092 0.07 DBMET00434 | DBMET00434 | |
| 0.042 | 0.054 | 0.066 | Acyl-CoA dehydrogenase inhibitor | 0.066 0.029 DBMET00434 | DBMET00434 | |
| 0.079 | 0.091 | 0.116 | UDP-glucose 4-epimerase inhibitor | 0.116 0.046 DBMET00434 | DBMET00434 | |
| 0.056 | 0.071 | 0.061 | Beta 2 adrenoreceptor agonist | 0.061 0.045 DBMET00434 | DBMET00434 | |
| 0.038 | 0.054 | 0.049 | Cholesterol esterase inhibitor | 0.049 0.031 DBMET00434 | DBMET00434 | |
| 0.062 | 0.078 | 0.068 | Peroxisome proliferator-activated receptor gamma antagonist | 0.068 0.057 DBMET00434 | DBMET00434 | |
| 0.034 | 0.052 | 0.047 | Mannosidase inhibitor | 0.047 0.028 DBMET00434 | DBMET00434 | |
| 0.02 | 0.038 | 0.025 | Vanilloid 2 agonist | 0.025 0.018 DBMET00434 | DBMET00434 | |
| 0.077 | 0.097 | 0.123 | Lanosterol 14 alpha demethylase inhibitor | 0.123 0.027 DBMET00434 | DBMET00434 | |
| 0.038 | 0.059 | 0.058 | Glucose-6-phosphate isomerase inhibitor | 0.058 0.02 DBMET00434 | DBMET00434 | |
| 0.079 | 0.102 | 0.093 | Bile acid receptor antagonist | 0.093 0.065 DBMET00434 | DBMET00434 | |
| 0.127 | 0.15 | 0.164 | ATPase inhibitor | 0.164 0.079 DBMET00434 | DBMET00434 | |
| 0.011 | 0.038 | 0.017 | Telomerase stimulant | 0.017 0.013 DBMET00434 | DBMET00434 | |
| 0.131 | 0.159 | 0.2 | Aldehyde oxidase inhibitor | 0.2 0.105 DBMET00434 | DBMET00434 | |
| 0.021 | 0.05 | 0.036 | Fumarate hydratase inhibitor | 0.036 0.022 DBMET00434 | DBMET00434 | |
| 0.024 | 0.054 | 0.032 | Peroxisome proliferator-activated receptor delta antagonist | 0.032 0.027 DBMET00434 | DBMET00434 | |
| 0.087 | 0.118 | 0.107 | Photosensitizer | 0.107 0.076 DBMET00434 | DBMET00434 | |
| 0.041 | 0.072 | 0.069 | Biliverdin reductase inhibitor | 0.069 0.033 DBMET00434 | DBMET00434 | |
| 0.029 | 0.062 | 0.045 | Peroxisome proliferator-activated receptor alpha agonist | 0.045 0.037 DBMET00434 | DBMET00434 | |
| 0.013 | 0.047 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.016 DBMET00434 | DBMET00434 | |
| 0.08 | 0.115 | 0.115 | Adenylate kinase inhibitor | 0.115 0.048 DBMET00434 | DBMET00434 | |
| 0.054 | 0.09 | 0.081 | Glutamate dehydrogenase inhibitor | 0.081 0.043 DBMET00434 | DBMET00434 | |
| 0.126 | 0.164 | 0.202 | Succinate dehydrogenase inhibitor | 0.202 0.048 DBMET00434 | DBMET00434 | |
| 0.031 | 0.07 | 0.047 | Kainate receptor agonist | 0.047 0.018 DBMET00434 | DBMET00434 | |
| 0.056 | 0.095 | 0.077 | Glycine receptor agonist | 0.077 0.043 DBMET00434 | DBMET00434 | |
| 0.016 | 0.056 | 0.024 | Nicotinic acid receptor 2 antagonist | 0.024 0.023 DBMET00434 | DBMET00434 | |
| 0.067 | 0.113 | 0.098 | NADH dehydrogenase inhibitor | 0.098 0.046 DBMET00434 | DBMET00434 | |
| 0.07 | 0.116 | 0.215 | GABA C receptor agonist | 0.215 0.018 DBMET00434 | DBMET00434 | |
| 0.123 | 0.171 | 0.165 | Insulin sensitizer | 0.165 0.113 DBMET00434 | DBMET00434 | |
| 0.02 | 0.071 | 0.025 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.025 0.023 DBMET00434 | DBMET00434 | |
| 0.032 | 0.084 | 0.063 | Argininosuccinate synthase inhibitor | 0.063 0.034 DBMET00434 | DBMET00434 | |
| 0.074 | 0.13 | 0.097 | Mucolytic | 0.097 0.082 DBMET00434 | DBMET00434 | |
| 0.017 | 0.075 | 0.029 | Purinergic P2Y15 antagonist | 0.029 0.02 DBMET00434 | DBMET00434 | |
| 0.063 | 0.124 | 0.087 | Creatine kinase inhibitor | 0.087 0.076 DBMET00434 | DBMET00434 | |
| 0.18 | 0.246 | 0.23 | Calcium channel activator | 0.23 0.172 DBMET00434 | DBMET00434 | |
| 0.033 | 0.1 | 0.069 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.069 0.027 DBMET00434 | DBMET00434 | |
| 0.062 | 0.13 | 0.085 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.085 0.073 DBMET00434 | DBMET00434 | |
| 0.026 | 0.095 | 0.04 | Thymidine kinase inhibitor | 0.04 0.03 DBMET00434 | DBMET00434 | |
| 0.103 | 0.176 | 0.151 | Melanin inhibitor | 0.151 0.08 DBMET00434 | DBMET00434 | |
| 0.009 | 0.085 | 0.025 | Uridine phosphorylase inhibitor | 0.025 0.023 DBMET00434 | DBMET00434 | |
| 0.047 | 0.124 | 0.083 | Ornithine decarboxylase inhibitor | 0.083 0.064 DBMET00434 | DBMET00434 | |
| 0.041 | 0.123 | 0.065 | Aminopeptidase I inhibitor | 0.065 0.06 DBMET00434 | DBMET00434 | |
| 0.177 | 0.259 | 0.304 | Antibacterial | 0.304 0.132 DBMET00434 | DBMET00434 | |
| 0.036 | 0.124 | 0.094 | Porphobilinogen synthase inhibitor | 0.094 0.039 DBMET00434 | DBMET00434 | |
| 0.102 | 0.199 | 0.156 | CF transmembrane conductance regulator agonist | 0.156 0.066 DBMET00434 | DBMET00434 | |
| 0.078 | 0.177 | 0.207 | Peroxidase inhibitor | 0.207 0.057 DBMET00434 | DBMET00434 | |
| 0.071 | 0.171 | 0.108 | Lipid peroxidase inhibitor | 0.108 0.107 DBMET00434 | DBMET00434 | |
| 0.043 | 0.145 | 0.068 | GABA aminotransferase inhibitor | 0.068 0.066 DBMET00434 | DBMET00434 | |
| 0.125 | 0.228 | 0.159 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.159 0.129 DBMET00434 | DBMET00434 | |
| 0.024 | 0.129 | 0.057 | Alcohol oxidase inhibitor | 0.057 0.038 DBMET00434 | DBMET00434 | |
| 0.058 | 0.164 | 0.106 | Cholesterol synthesis inhibitor | 0.106 0.08 DBMET00434 | DBMET00434 | |
| 0.061 | 0.169 | 0.081 | Vanilloid agonist | 0.081 0.067 DBMET00434 | DBMET00434 | |
| 0.034 | 0.146 | 0.072 | Purinergic P2X1 antagonist | 0.072 0.03 DBMET00434 | DBMET00434 | |
| 0.018 | 0.135 | 0.03 | Glutamate (mGluR3) agonist | 0.03 0.028 DBMET00434 | DBMET00434 | |
| 0.095 | 0.214 | 0.134 | Interferon gamma antagonist | 0.134 0.103 DBMET00434 | DBMET00434 | |
| 0.038 | 0.165 | 0.061 | Interferon inducer | 0.061 0.051 DBMET00434 | DBMET00434 | |
| 0.042 | 0.179 | 0.08 | Alcohol dehydrogenase inhibitor | 0.08 0.079 DBMET00434 | DBMET00434 | |
| 0.122 | 0.263 | 0.207 | Transcription factor NF kappa B inhibitor | 0.207 0.162 DBMET00434 | DBMET00434 | |
| 0.142 | 0.285 | 0.225 | Sodium/bile acid cotransporter inhibitor | 0.225 0.156 DBMET00434 | DBMET00434 | |
| 0.092 | 0.238 | 0.155 | Immunostimulant | 0.155 0.15 DBMET00434 | DBMET00434 | |
| 0.026 | 0.177 | 0.081 | Phenylalanine 4-hydroxylase inhibitor | 0.081 0.037 DBMET00434 | DBMET00434 | |
| 0.048 | 0.219 | 0.089 | Xanthine oxidase inhibitor | 0.089 0.073 DBMET00434 | DBMET00434 | |
| 0.056 | 0.239 | 0.103 | DOPA decarboxylase inhibitor | 0.103 0.07 DBMET00434 | DBMET00434 | |
| 0.022 | 0.206 | 0.422 | DNA gyrase subunit A inhibitor | 0.422 0.001 DBMET00434 | DBMET00434 | |
| 0.017 | 0.268 | 0.19 | Potassium channel Kv1.5 blocker | 0.19 0.005 DBMET00434 | DBMET00434 | |
| 0.032 | 0.326 | 0.405 | Cyclooxygenase 2 inhibitor | 0.405 0.005 DBMET00434 | DBMET00434 | |
| 0.068 | 0.375 | 0.194 | Lipoxygenase inhibitor | 0.194 0.147 DBMET00434 | DBMET00434 | |
| 0.033 | 0.379 | 0.446 | Cyclooxygenase inhibitor | 0.446 0.005 DBMET00434 | DBMET00434 | |
| 0.025 | 0.392 | 0.736 | Cyclooxygenase 1 inhibitor | 0.736 0.004 DBMET00434 | DBMET00434 | |
| 0.01 | 0.491 | 0.378 | DNA topoisomerase IV inhibitor | 0.378 0.002 DBMET00434 | DBMET00434 | |
| 0.042 | 0.546 | 0.485 | Immunosuppressant | 0.485 0.037 DBMET00434 | DBMET00434 | |
| 0.006 | 0.675 | 0.169 | DNA gyrase inhibitor | 0.169 0.006 DBMET00434 | DBMET00434 | |
| 0.005 | 0.763 | 0.568 | 5-Lipoxygenase inhibitor | 0.568 0.004 DBMET00434 | DBMET00434 | |
| 0.006 | 0.8 | 0.332 | Topoisomerase II inhibitor | 0.332 0.015 DBMET00434 | DBMET00434 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |